275 related articles for article (PubMed ID: 15505016)
1. Effects of mixing glargine and short-acting insulin analogs on glucose control.
Kaplan W; Rodriguez LM; Smith OE; Haymond MW; Heptulla RA
Diabetes Care; 2004 Nov; 27(11):2739-40. PubMed ID: 15505016
[No Abstract] [Full Text] [Related]
2. Mixing insulin lispro and ultralente insulin.
Bastyr EJ; Holcombe JH; Anderson JH; Clore JN
Diabetes Care; 1997 Jun; 20(6):1047-8. PubMed ID: 9167130
[No Abstract] [Full Text] [Related]
3. Nocturnal glucose control and free insulin levels in children with type 1 diabetes by use of the long-acting insulin HOE 901 as part of a three-injection regimen.
Mohn A; Strang S; Wernicke-Panten K; Lang AM; Edge JA; Dunger DB
Diabetes Care; 2000 Apr; 23(4):557-9. PubMed ID: 10857953
[No Abstract] [Full Text] [Related]
4. Both continuous subcutaneous insulin infusion and a multiple daily insulin injection regimen with glargine as basal insulin are equally better than traditional multiple daily insulin injection treatment.
Lepore G; Dodesini AR; Nosari I; Trevisan R
Diabetes Care; 2003 Apr; 26(4):1321-2. PubMed ID: 12663625
[No Abstract] [Full Text] [Related]
5. [Flexible intensive insulin therapy: a change in mentalities].
Penfornis A; Chabroux S; Grimaldi A
Rev Med Interne; 2008 Nov; 29(11):857-60. PubMed ID: 18387717
[No Abstract] [Full Text] [Related]
6. Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.
Rossetti P; Pampanelli S; Fanelli C; Porcellati F; Costa E; Torlone E; Scionti L; Bolli GB
Diabetes Care; 2003 May; 26(5):1490-6. PubMed ID: 12716810
[TBL] [Abstract][Full Text] [Related]
7. Early pharmacokinetic and pharmacodynamic effects of mixing lispro with glargine insulin: results of glucose clamp studies in youth with type 1 diabetes.
Cengiz E; Tamborlane WV; Martin-Fredericksen M; Dziura J; Weinzimer SA
Diabetes Care; 2010 May; 33(5):1009-12. PubMed ID: 20150302
[TBL] [Abstract][Full Text] [Related]
8. The insulin analog glargine during an unplanned pregnancy.
Cechurová D; Lacigová S; Jankovec Z; Haladová I; Zourek M; Krcma M; Rusavý Z; Turek J
Wien Klin Wochenschr; 2006 Oct; 118(19-20):619-20. PubMed ID: 17136338
[No Abstract] [Full Text] [Related]
9. Optimal timing of injection of once-daily insulin glargine in people with Type 1 diabetes using insulin lispro at meal-times.
Ashwell SG; Gebbie J; Home PD
Diabet Med; 2006 Jan; 23(1):46-52. PubMed ID: 16409565
[TBL] [Abstract][Full Text] [Related]
10. Optimizing glycemic control with insulin glargine.
Williams JB
Diabetes Technol Ther; 2003; 5(3):471-3. PubMed ID: 12828834
[No Abstract] [Full Text] [Related]
11. Treatment of adolescents with type 1 diabetes mellitus.
Garg S; Chase HP
J Pediatr Endocrinol Metab; 2004 May; 17(5):805-6. PubMed ID: 15237718
[No Abstract] [Full Text] [Related]
12. Optimal administration of lispro insulin in hyperglycemic type 1 diabetes.
Rassam AG; Zeise TM; Burge MR; Schade DS
Diabetes Care; 1999 Jan; 22(1):133-6. PubMed ID: 10333914
[TBL] [Abstract][Full Text] [Related]
13. [Advantages of fast-acting insulin analogs: preprandial greater HbA1c lowering -- postprandial lower weight].
MMW Fortschr Med; 2005 Aug; 147(33-34):45. PubMed ID: 16138637
[No Abstract] [Full Text] [Related]
14. Novel insulins: expanding options in diabetes management.
Gerich JE
Am J Med; 2002 Sep; 113(4):308-16. PubMed ID: 12361817
[TBL] [Abstract][Full Text] [Related]
15. Use of a novel double-antibody technique to describe the pharmacokinetics of rapid-acting insulin analogs.
Lindström T; Hedman CA; Arnqvist HJ
Diabetes Care; 2002 Jun; 25(6):1049-54. PubMed ID: 12032113
[TBL] [Abstract][Full Text] [Related]
16. Improved glycemic control without an increase in severe hypoglycemic episodes in intensively treated patients with type 1 diabetes receiving morning, evening, or split dose insulin glargine.
Garg SK; Gottlieb PA; Hisatomi ME; D'Souza A; Walker AJ; Izuora KE; Chase HP
Diabetes Res Clin Pract; 2004 Oct; 66(1):49-56. PubMed ID: 15364161
[TBL] [Abstract][Full Text] [Related]
17. Reducing mistakes in patient administration of glargine and lispro.
Schutta MH
Diabetes Care; 2002 Jun; 25(6):1098-9. PubMed ID: 12032124
[No Abstract] [Full Text] [Related]
18. Switching to multiple daily injection therapy with glulisine improves glycaemic control, vascular damage and treatment satisfaction in basal insulin glargine-injected diabetic patients.
Yanagisawa K; Ashihara J; Obara S; Wada N; Takeuchi M; Nishino Y; Maeda S; Ishibashi Y; Yamagishi S
Diabetes Metab Res Rev; 2014 Nov; 30(8):693-700. PubMed ID: 24639403
[TBL] [Abstract][Full Text] [Related]
19. Improved glycemic control with insulin aspart: a multicenter randomized double-blind crossover trial in type 1 diabetic patients. UK Insulin Aspart Study Group.
Home PD; Lindholm A; Hylleberg B; Round P
Diabetes Care; 1998 Nov; 21(11):1904-9. PubMed ID: 9802741
[TBL] [Abstract][Full Text] [Related]
20. The effect of the insulin analog lispro on nighttime blood glucose control in type 1 diabetic patients.
Ahmed AB; Home PD
Diabetes Care; 1998 Jan; 21(1):32-7. PubMed ID: 9538967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
